Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Asia Pacific Gastrointestinal Drugs Market

ID: MRFR/Pharma/0190-CR
106 Pages
Rahul Gotadki
Last Updated: February 24, 2026

Asia-Pacific Gastrointestinal Drugs Market Research Report Information: By Drug Class (Acid Neutralizers, Laxatives & Antidiarrheal, Anti-Emetics, Antiulcer), Type Of Disease (Esophagus Diseases, Stomach Diseases, Intestinal Diseases, Rectum Diseases) and Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Asia Pacific Gastrointestinal Drugs Market Infographic
Purchase Options
  1. 1 Report Prologue
  2. 2 Introduction
    1. 2.1 Scope of Study 14
    2. 2.2 Research Objective 14
    3. 2.3 Assumptions & Limitations 14
      1. 2.3.1 Assumptions 14
      2. 2.3.2 Limitations 14
    4. 2.4 Market Structure 15
  3. 3 Research Methodology
    1. 3.1 Primary Research 18
    2. 3.2 Secondary Research 18
    3. 3.3 Market Size Estimation 18
      1. 3.3.1 Market Share analysis 19
    4. 3.4 Market Pricing Approach 20
  4. 4 Market Dynamics
    1. 4.1 Introduction 21
    2. 4.2 Drivers 22
      1. 4.2.1 Increasing prevalence of gastrointestinal diseases 22
      2. 4.2.2 Increasing investments and funding in the field of life science research 22
      3. 4.2.3 Increasing awareness among the people 23
      4. 4.2.4 Growing geriatric population 23
      5. 4.2.5 Changing reimbursement policies 23
    3. 4.3 Restraints 24
      1. 4.3.1 Presence of misbranded and spurious drugs 24
    4. 4.4 Opportunities 24
      1. 4.4.1 Development of new drugs 24
  5. 5 Market Factor Analysis
    1. 5.1 Porters Five forces Model 25
      1. 5.1.1 Bargaining Power Of Suppliers 26
      2. 5.1.2 Bargaining Power Of Buyers 26
      3. 5.1.3 Threat Of New Entrants 26
      4. 5.1.4 Threat Of Substitutes 26
      5. 5.1.5 Intensity Of Rivalry 26
    2. 5.2 Value Chain Analysis 27
      1. 5.2.1 R&D 27
      2. 5.2.2 Manufacturing 27
      3. 5.2.3 Distribution & Sales 28
      4. 5.2.4 Post-Sales Monitoring 28
    3. 5.3 Demand & Supply: Gap Analysis 28
    4. 5.4 Pricing Analysis 29
    5. 5.5 Investment Opportunity Analysis 29
    6. 5.6 Market Access Analysis 29
  6. 6 Asia Pacific Gastrointestinal Drugs Market, By Drug Class
    1. 6.1 Introduction 30
    2. 6.2 Acid Neutralizers 32
    3. 6.3 Laxatives and Antidiarrheal 33
    4. 6.4 Antiemetics 34
    5. 6.5 Antiulcer 34
  7. 7 Asia Gastrointestinal Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
    1. 7.1 Introduction 35
    2. 7.2 Esophagus diseases 37
    3. 7.3 Stomach diseases 38
    4. 7.4 Intestinal diseases 38
    5. 7.5 Rectum Diseases 39
  8. 8 Asia Pacific Gastrointestinal Drugs Market, By Region
    1. 8.1 Introduction 40
    2. 8.2 Japan 42
  9. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  10. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
    1. 8.3 China 44
  11. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  12. Asia Gastrointestinal Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
    1. 8.4 India 46
  13. Asia Gastrointestinal Drugs Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  14. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
    1. 8.5 Korea 48
  15. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  16. Asia Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
    1. 8.6 Rest of Asia 51
  17. Asia Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  18. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  19. 8.6.1 Malaysia 54
  20. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  21. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  22. 8.6.2 Singapore 56
  23. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  24. Asia Gastrointestinal Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  25. 8.6.3 Indonesia 59
  26. Asia Gastrointestinal Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  27. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  28. 8.6.4 Thailand 61
  29. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  30. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  31. 8.6.5 Philippines 64
  32. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  33. Asia Gastrointestinal Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  34. 8.6.6 Vietnam 66
  35. Asia Gastrointestinal Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  36. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  37. 8.6.7 Others 68
  38. Asia Pacific Gastrointestinal Drugs Market, By Drug Class
  39. Asia Pacific Gastrointestinal Drugs Market, By Type of Diseases
  40. 9 Company Profile
    1. 9.1 Abbott 71
      1. 9.1.1 Company Overview 71
      2. 9.1.2 Product/Business Segment Overview 71
      3. 9.1.3 Financial Overview 72
      4. 9.1.4 Key Development 74
      5. 9.1.5 SWOT Analysis 75
    2. 9.2 Allergan Plc 76
      1. 9.2.1 Company Overview 76
      2. 9.2.2 Product/Business Segment Overview 76
      3. 9.2.3 Financial Overview 77
      4. 9.2.4 Key Developments 78
      5. 9.2.5 SWOT Analysis 78
    3. 9.3 AstraZeneca 79
      1. 9.3.1 Company Overview 79
      2. 9.3.2 Product/Business Segment Overview 79
      3. 9.3.3 Financial Overview 80
      4. 9.3.4 Key Development 81
      5. 9.3.5 SWOT Analysis 82
    4. 9.4 Eli Lilly Company 83
      1. 9.4.1 Company Overview 83
      2. 9.4.2 Product/Business Segment Overview 83
      3. 9.4.3 Financial Overview 83
      4. 9.4.4 Key Development 84
      5. 9.4.5 SWOT Analysis 85
    5. 9.5 F. Hoffmann-La Roche Ltd 86
      1. 9.5.1 Overview 86
      2. 9.5.2 Product/Business Segment Overview 86
      3. 9.5.3 Financial Overview 86
      4. 9.5.4 Key Development 87
      5. 9.5.5 SWOT Analysis 88
    6. 9.6 GlaxoSmithKline plc. 89
      1. 9.6.1 Company Overview 89
      2. 9.6.2 Product/ Business segment overview 89
      3. 9.6.3 Financial Overview 89
      4. 9.6.4 Key Development 91
      5. 9.6.5 SWOT Analysis 92
    7. 9.7 Pfizer Inc 93
      1. 9.7.1 Overview 93
      2. 9.7.2 Product/Business Segment Overview 93
      3. 9.7.3 Financial Overview 93
      4. 9.7.4 Key Development 94
      5. 9.7.5 SWOT Analysis 95
    8. 9.8 Valeant Pharmaceuticals 96
      1. 9.8.1 Company Overview 96
      2. 9.8.2 Product overview 96
      3. 9.8.3 Financial Overview 97
      4. 9.8.4 Key Development 98
      5. 9.8.5 SWOT Analysis 99
  41. 10 Company Landscape
    1. 10.1 Introduction 100
    2. 10.2 Company Share Analysis 100
    3. 10.3 Key Developments 101
  42. 11 Conclusion
    1. 11.1 Key Findings 103
      1. 11.1.1 CEO’s Viewpoint 103
      2. 11.1.2 Unmet Needs 103
      3. 11.1.3 Key Companies to Watch 103
      4. 11.1.4 Prediction of Asia Gastrointestinal Drugs Industry 103
  43. 12 Appendix
    1. 12.1 Discussion Blue Print 104
    2. 12.2 References 105
  44. 13 List of Tables
  45. TABLE 1 PRIMARY INTERVIEWS 19
  46. TABLE 2 ASIA GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS, 2020-2027 (USD MILLION) 31
  47. TABLE 3 ACID NEUTRALIZERS Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 32
  48. TABLE 4 Asia Pacific Gastrointestinal Drugs Market, BY REGION,
  49. Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 34
  50. Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 34
  51. Asia Pacific Gastrointestinal Drugs Market, BY TYPE OF DISEASES, 2020-2027 (USD MILLION) 36
  52. TABLE 8 ESOPHAGUS DISEASES Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 37
  53. TABLE 9 Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 38
  54. Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 38
  55. Asia Pacific Gastrointestinal Drugs Market, BY REGION , 2020-2027 (USD MILLION) 39
  56. Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020-2027 (USD MILLION) 41
  57. TABLE 13 JAPAN GASTROINTESTINAL DRUGS Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 42
  58. TABLE 14 JAPAN GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY TYPE OF DISEASES , 2020-2027 (USD MILLION) 43
  59. TABLE 15 CHINA Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 44
  60. TABLE 16 Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 45
  61. Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 46
  62. Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 47
  63. TABLE 19 KOREA GASTROINTESTINAL DRUGS Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 48
  64. TABLE 20 KOREA GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 50
  65. TABLE 21 REST Asia Pacific Gastrointestinal Drugs Market, BY REGION , 2020-2027 (USD MILLION) 51
  66. Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 52
  67. Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 53
  68. TABLE 24 MALAYSIA GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 54
  69. TABLE 25 MALAYSIA Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 55
  70. Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 56
  71. Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 57
  72. Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 59
  73. TABLE 29 INDONESIA GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 60
  74. TABLE 30 THAILAND Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 61
  75. TABLE 31 Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 62
  76. Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 64
  77. Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 65
  78. TABLE 34 VIETNAM GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 66
  79. TABLE 35 VIETNAM GASTROINTESTINAL Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 67
  80. TABLE 36 OTHERS Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS , 2020-2027 (USD MILLION) 68
  81. TABLE 37 Asia Pacific Gastrointestinal Drugs Market, BY TYPES OF DISEASES, 2020-2027 (USD MILLION) 70
  82. TABLE 38 ABBOTT: KEY DEVELOPMENT 74
  83. TABLE 39 ALLERGAN: KEY DEVELOPMENT 78
  84. TABLE 40 ASTRAZENECA: KEY DEVELOPMENT 81
  85. TABLE 41 ELI LILLY COMPANY : KEY DEVELOPMENT 84
  86. TABLE 42 F. HOFFMANN-LA ROCHE AG: KEY DEVELOPMENT 87
  87. TABLE 43 GLAXOSMITHKLINE: KEY DEVELOPMENT 91
  88. TABLE 44 VALEANT PHARMACEUTICALS: KEY DEVELOPMENT 98
  89. 14 List of Figures
  90. FIGURE 1 Asia Pacific Gastrointestinal Drugs Market, BY DRUG TYPE, 2020 (%) 11
  91. FIGURE 2 Asia Pacific Gastrointestinal Drugs Market, BY TYPE OF DISEASES, 2020 (%) 12
  92. FIGURE 3 Asia Pacific Gastrointestinal Drugs Market, BY REGION, 2020 (%) 12
  93. FIGURE 4 ASIA GASTROINTESTINAL DRUGS MARKET: MARKET STRUCTURE 15
  94. FIGURE 5 RESEARCH PROCESS 16
  95. FIGURE 6 DRIVERS & RESTRAINTS IMPACT ANALYSIS OF ASIA GASTROINTESTINAL DRUG MARKET 21
  96. FIGURE 7 PORTERS FIVE FORCES MODEL 25
  97. FIGURE 8 VALUE CHAIN: GASTROINTESTINAL DRUGS 27
  98. Asia Pacific Gastrointestinal Drugs Market, BY DRUG CLASS 2020 & 2027 (USD MILLION) 30
  99. FIGURE 10 ASIA GASTROINTESTINAL DRUGS Asia Pacific Gastrointestinal Drugs Market, BY TYPE OF DISEASES 2020 & 2027 (USD MILLION) 36
  100. FIGURE 11 ASIA Asia Pacific Gastrointestinal Drugs Market, BY REGION 2020 & 2027 (USD MILLION) 41
  101. FIGURE 12 ABBOTT: RECENT FINANCIALS (USD MILLION) 72
  102. FIGURE 13 ABBOTT: GEOGRAPHICAL MIX, 2020 (%) 73
  103. FIGURE 14 ABBOTT: SEGMENTAL MIX, 2020 (%) 73
  104. FIGURE 15 ABBOTT LABORATORIES: SWOT ANALYSIS 75
  105. FIGURE 16 ALLERGAN REVENUE 2020-2020 77
  106. FIGURE 17 ALLERGAN BUSINESS AND GEOGRAPHIC REVENUE MIX 77
  107. FIGURE 18 ALLERGAN: SWOT ANALYSIS 78
  108. FIGURE 19 ASTRAZENECA: RECENT FINANCIAL 80
  109. FIGURE 20 ASTRAZENECA: GEOGRAPHICAL MIX 80
  110. FIGURE 21 ASTRAZENECA: OPERATING SEGMENTS MIX 81
  111. FIGURE 22 ASTRAZENECA: SWOT ANALYSIS 82
  112. FIGURE 23 ELI LILLY COMPANY : RECENT FINANCIAL 83
  113. FIGURE 24 ELI LILLY COMPANY : BUSINESS REVENUE MIX (2020) 84
  114. FIGURE 25 ELI LILLY COMPANY : GEOGRAPHIC REVENUE MIX 84
  115. FIGURE 26 ELI LILLY COMPANY : SWOT ANALYSIS 85
  116. FIGURE 27 F. HOFFMANN-LA ROCHE AG: RECENT FINANCIAL (SALES) 86
  117. FIGURE 28 F. HOFFMANN-LA ROCHE AG: SEGMENTAL MIX (%) 87
  118. FIGURE 29 F. HOFFMANN-LA ROCHE AG: GEOGRPAHICAL MIX 87
  119. FIGURE 30 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 88
  120. FIGURE 31 GLOAXOSMITHKLINE: RECENT FINANCIAL 89
  121. FIGURE 32 GLAXOSMITHKLINE: OPERATING SEGMENT MIX 90
  122. FIGURE 33 GLAXOSMITHKLINE: GEOGRAPHICAL MIX 90
  123. FIGURE 34 GLAXOSMITHKLINE: SWOT ANALYSIS 92
  124. FIGURE 35 PFIZER FINANCIAL DATA: REVENUE AND R&D 93
  125. FIGURE 36 PFIZER FINANCIAL DATA SEGMENTAL MIX 94
  126. FIGURE 37 PFIZER FINANCIAL DATA GEOGRAPHICAL MIX 94
  127. FIGURE 38 PFIZER: SWOT ANALYSIS 95
  128. FIGURE 39 VALEANT PHARMACEUTICALS REVENUE 97
  129. FIGURE 40 VALEANT PHARMACEUTICALS SEGMENTAL REVENUE 97
  130. FIGURE 41 VALEANT PHARMACEUTICALS GEOGRAPHICAL REVENUE 98
  131. FIGURE 42 VALEANT PHARMACEUTICALS: SWOT ANALYSIS 99
  132. FIGURE 43 ASIA GASTROINTESTINAL DRUGS COMPANY SHARE ANALYSIS, 2020 (%) 100

Asia-Pacific Gastrointestinal Drugs Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions